risk of ovarian malignancy algorithm (roma)

What is the Risk of Ovarian Malignancy Algorithm (ROMA)?

The Risk of Ovarian Malignancy Algorithm (ROMA) is a diagnostic tool used in gynecology to assess the likelihood that an ovarian mass is malignant. It combines the levels of two biomarkers, Human Epididymis Protein 4 (HE4) and CA-125, with a patient's menopausal status to stratify the risk of ovarian cancer.

Frequently asked queries:

What is the Risk of Ovarian Malignancy Algorithm (ROMA)?
How is ROMA Calculated?
Why are HE4 and CA-125 Important?
What are the Benefits of Using ROMA?
Who Should Undergo ROMA Testing?
What are the Limitations of ROMA?
How is the ROMA Score Interpreted?
What is the Clinical Impact of ROMA?
What Role Do Whole Foods Play in Preventing Gynecological Cancers?
Which Conditions are Typically Screened?
How Can Gynecology Practices Enhance Cybersecurity?
What are the Implications of PTU in Pregnancy?
What is CAR T-Cell Therapy?
What are the risks associated with gynecological surgeries?
What is the Future of Hormonal Treatments in Gynecology?
How to Prepare for a Needle Biopsy?
Who Should Attend Parenting Classes?
Why Do Regular Contractions Occur?
What Are Reproductive Disorders?
How Does FAFSA Impact Medical Education?
Follow Us
Top Searches
Cystic Ovarian Disease Ectopic Pregnancy Endometriosis Menorrhagia Ultrasound

Partnered Content Networks

Relevant Topics